Brian Conway

6.1k total citations
86 papers, 2.1k citations indexed

About

Brian Conway is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Brian Conway has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hepatology, 50 papers in Epidemiology and 47 papers in Infectious Diseases. Recurrent topics in Brian Conway's work include Hepatitis C virus research (55 papers), HIV/AIDS drug development and treatment (38 papers) and Hepatitis B Virus Studies (31 papers). Brian Conway is often cited by papers focused on Hepatitis C virus research (55 papers), HIV/AIDS drug development and treatment (38 papers) and Hepatitis B Virus Studies (31 papers). Brian Conway collaborates with scholars based in Canada, United States and Australia. Brian Conway's co-authors include Jason Grebely, Jesse D. Raffa, Mark Tyndall, Fiona Duncan, Krista Genoway, Mel Krajden, Stanley DeVlaming, Calvin Lai, Mark Viljoen and Milan Khara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Brian Conway

83 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Conway Canada 25 1.5k 1.3k 889 458 124 86 2.1k
Mamta K. Jain United States 24 1.0k 0.7× 799 0.6× 586 0.7× 229 0.5× 227 1.8× 113 1.8k
Lisette Johnson United States 9 1.2k 0.8× 811 0.6× 664 0.7× 195 0.4× 165 1.3× 9 1.6k
L Molé United States 26 2.3k 1.6× 1.7k 1.3× 1.3k 1.5× 526 1.1× 328 2.6× 57 3.3k
Lars Peters Denmark 21 1.0k 0.7× 993 0.8× 438 0.5× 115 0.3× 173 1.4× 52 1.6k
Edward R. Cachay United States 23 1.1k 0.7× 607 0.5× 480 0.5× 138 0.3× 114 0.9× 95 1.5k
Pablo Labarga Spain 36 2.2k 1.5× 2.1k 1.6× 2.0k 2.2× 849 1.9× 617 5.0× 137 3.8k
Josep M. Gatell Spain 22 780 0.5× 360 0.3× 991 1.1× 575 1.3× 233 1.9× 61 1.6k
Oluwaseun Falade‐Nwulia United States 20 1.1k 0.8× 1.0k 0.8× 393 0.4× 73 0.2× 51 0.4× 75 1.6k
Anne F. Luetkemeyer United States 20 863 0.6× 490 0.4× 851 1.0× 135 0.3× 93 0.8× 58 1.5k
Anders Blaxhult Sweden 26 959 0.7× 249 0.2× 1.6k 1.8× 1.0k 2.3× 498 4.0× 73 2.2k

Countries citing papers authored by Brian Conway

Since Specialization
Citations

This map shows the geographic impact of Brian Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Conway more than expected).

Fields of papers citing papers by Brian Conway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Conway. The network helps show where Brian Conway may publish in the future.

Co-authorship network of co-authors of Brian Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Conway. A scholar is included among the top collaborators of Brian Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Conway. Brian Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Kenneth, et al.. (2023). Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic. Journal of Addiction Medicine. 17(6). e374–e381. 4 indexed citations
3.
Dalgård, Olav, Alain H. Litwin, Oren Shibolet, et al.. (2022). Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection. Journal of Addictive Diseases. 41(3). 213–224. 3 indexed citations
4.
Farag, Mina, Scott Fung, Edward Tam, et al.. (2021). Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study. Journal of Viral Hepatitis. 28(6). 942–950. 18 indexed citations
5.
Cooper, Curtis, David Wong, Sarah Haylock‐Jacobs, et al.. (2020). Distinct Hepatitis B and HIV co‐infected populations in Canada. Journal of Viral Hepatitis. 28(3). 517–527. 1 indexed citations
6.
Cooper, Curtis, Daniel Read, Marie-Louise Vachon, et al.. (2020). Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants. BMC Public Health. 20(1). 1345–1345. 7 indexed citations
7.
Golizeh, Makan, Carlos E Melendez-Peña, Brian J. Ward, et al.. (2018). Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging. PLoS ONE. 13(4). e0195148–e0195148. 5 indexed citations
8.
Lamoury, F., Behzad Hajarizadeh, Evan B. Cunningham, et al.. (2017). Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse. Journal of Clinical Virology. 92. 32–38. 24 indexed citations
9.
Conway, Brian, et al.. (2016). Retrospective Analysis of Recurrent HCV Viremia in High-risk HIV Co-infected People Who Inject Drugs (PWID). 2(2). 1 indexed citations
10.
Elion, Richard, Jean‐Michel Molina, José Ramón Arribas, et al.. (2013). A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(4). 494–497. 33 indexed citations
11.
12.
Grebely, Jason, Elizabeth Knight, Krista Genoway, et al.. (2010). Reinfection with hepatitis C virus following sustained virological response in injection drug users. Journal of Gastroenterology and Hepatology. 25(7). 1281–1284. 59 indexed citations
13.
Grebely, Jason, Krista Genoway, Milan Khara, et al.. (2007). Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. International Journal of Drug Policy. 18(5). 437–443. 87 indexed citations
14.
Hecht, Frederick, Lei Wang, Ann C. Collier, et al.. (2006). A Multicenter Observational Study of the Potential Benefits of Initiating Combination Antiretroviral Therapy during Acute HIV Infection. The Journal of Infectious Diseases. 194(6). 725–733. 131 indexed citations
15.
Dezube, Bruce J., John P. Doweiko, Brian Conway, et al.. (2004). Monoclonal antibody hNM01 in HIV-infected patients: a phase I study. Journal of Clinical Virology. 31. 45–47. 9 indexed citations
16.
Baril, Jean-Guy, Éric Lefebvre, Richard Lalonde, Stephen D. Shafran, & Brian Conway. (2003). Nelfinavir and Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Salvage Regimes in Heavily Hiv Pretreated Patients. Canadian Journal of Infectious Diseases and Medical Microbiology. 14(4). 201–205. 3 indexed citations
17.
Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 23 indexed citations
18.
Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 16 indexed citations
19.
Conway, Brian. (2000). Initial Therapy with Protease Inhibitor-Sparing Regimens: Evaluation of Nevirapine and Delavirdine. Clinical Infectious Diseases. 30(Supplement_2). S130–S134. 11 indexed citations
20.
Rae, Sandra, Janet Raboud, Brian Conway, et al.. (1998). Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent. AIDS. 12(16). 2185–2192. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamta K. Jain Breakdown of academic impact, for papers by Lisette Johnson Breakdown of academic impact, for papers by L Molé Breakdown of academic impact, for papers by Lars Peters Breakdown of academic impact, for papers by Edward R. Cachay Breakdown of academic impact, for papers by Pablo Labarga Breakdown of academic impact, for papers by Josep M. Gatell Breakdown of academic impact, for papers by Oluwaseun Falade‐Nwulia Breakdown of academic impact, for papers by Anne F. Luetkemeyer Breakdown of academic impact, for papers by Anders Blaxhult
Rankless by CCL
2026